1 / 1

Mycoplasma Testing Market Size & Share

Mycoplasma Testing Market

Anjali228
Download Presentation

Mycoplasma Testing Market Size & Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The global mycoplasma testing market is projected to grow from $972.3 million in 2025 to $1.39 billion by 2032, with a 5.3% CAGR. North America dominates with a 49.02% market share, driven by research activities and R&D investments. Key highlights:  Mycoplasma contamination affects 15-35% of continuous cell cultures globally  Reagents & kits segment leads the market due to high usage in research labs  PCR-based testing methods hold the largest share due to high sensitivity  Biopharmaceutical companies are the primary end-users  COVID-19 positively impacted the market through increased vaccine development testing Market constraints include high testing costs and a shortage of trained professionals, particularly affecting adoption in emerging markets. Recent developments show industry consolidation, with SD Biosensor acquiring Meridian Bioscience in January 2023, and significant investments like Pfizer's $100 million research partnership with Flagship Pioneering in July 2023. Report- Fortune Business Insights - Mycoplasma Testing Market Size, Share | Growth Report [2032] https://www.fortunebusinessinsights.com/mycoplasma-testing-market-108687

More Related